Total en bloc spondylectomy for spinal tumors: improvement of the technique and its associated basic background  by Tomita, Katsuro et al.
J Orthop Sci (2006) 11:3–12
DOI 10.1007/s00776-005-0964-y
Invited review
Total en bloc spondylectomy for spinal tumors: improvement of
the technique and its associated basic background
Katsuro Tomita, Norio Kawahara, Hideki Murakami, and Satoru Demura
Department of Orthopaedic Surgery, School of Medicine, Kanazawa University, 13-1 Takaramachi, Kanazawa 920-8641, Japan
surgical techniques. A review of the developmental
process of this operation leads to recognition of the tips,
pitfalls, and solutions. We review here the principal
concepts of TES for spinal tumors, as well as their re-
lated basic works that support the rationality of this
operation.
Principal concept
1. Oncologic concept of spinal tumors (compartment
and barriers)
Enneking et al. examined the process of local spread of
primary bone and soft tissue tumors of the extremities
and proposed a “surgical staging system” and “the con-
cept of compartment and anatomic barriers.”17 Apply-
ing this concept to the spine, we studied the histology
of 19 vertebral tumor specimens resected by TES.
We found that the following tissues served as barriers
to spinal tumor progression;1 the anterior longitudinal
ligament (ALL), posterior longitudinal ligament
(PLL), periosteum abutting the spinal canal, ligamen-
tum flavum, periosteum of the lamina and spinal
process, interspinous ligament, supraspinous ligament,
cartilaginous endplate, and cartilaginous annulus fibro-
sus. However, both the PLL and the periosteum on the
lateral side of the vertebral body were weak anatomical
barriers. In contrast, the ALL, cartilaginous endplate,
and annulus fibrosus were much stronger barriers.1 We
concluded that in the spine one vertebra could be re-
garded a single oncologic compartment and the above-
mentioned surrounding tissues as barriers to tumor
spread (Fig. 1).
2. Surgical classification of spinal tumors
We devised a surgical classification of spinal tumors2,3
based on both the pattern of local vertebral tumor
Introduction
Conventionally, curettage or piecemeal excision of ver-
tebral tumors has been commonly practiced. However,
clear disadvantages of these approaches include a high
risk of tumor cell contamination of the surrounding
structures and residual tumor tissue at the site due to
the difficulty of distinguishing tumor from healthy tis-
sue. These factors contribute to incomplete resection of
the tumor as well as high local recurrence rates of spinal
malignant tumors.1–3
Roy-Camille et al.,4,5 Stener,6–8 Stener and Johnsen,9
Sundaresan et al.,10 and Boriani et al.11,12 have described
total corpectomy or spondylectomy for reducing local
recurrence of a vertebral tumor, with excellent clinical
results. Our own group has developed a new surgical
technique of spondylectomy (vertebrectomy) termed
total en bloc spondylectomy (TES).2,3,13–16 Our technique
is different from the spondylectomy mentioned above
in that it involves en bloc removal of the lesion, that is,
removal of the whole vertebra, both body and lamina as
one compartment.
The TES procedure has been increasingly gaining
recognition and is now widely accepted by spinal and
musculoskeletal tumor surgeons a decade and a half
after its development in 1989. This surgery is regarded
as one of the most sophisticated and demanding ope-
rations; it requires a high level of technical ability
and adequate knowledge and consideration of surgical
anatomy, physiology, and biomechanics of both the
spine and spinal cord. This level of understanding is not
limited to oncological surgery but should be applied
when surgically managing conditions of the spine and
the spinal cord. The surgical skill of spine surgeons im-
proves during the process of learning each step of these
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progression and the type of surgery used to excise it.
Primary or secondary malignant tumors frequently
grow or settle in the middle posterior part of the verte-
bral body, from where they can easily extend to the
posterior arch through the pedicles (“intracompar-
tmental lesions, type 1, 2, and 3 lesions”). This tumor
then generally grows outside the compartment (extra-
compartmentally) into the spinal canal (type 4) or
extends outside of the vertebra (type 5) and finally to
the adjacent vertebra(e) (type 6). “Multiple” (type 7
lesions) naturally implies multiple-skip lesions in the
spinal column, which may be skipping, secondary, or
tertiary metastases (Fig. 2).
A wide surgical margin or at least a marginal mar-
gin1,17 is achievable around the affected vertebra when
the lesion is intracompartmental (type 1, 2, or 3), par-
ticularly when the vertebra is cut at the healthy part of
the pedicle or lamina. For type 4 or for a tumor invading
the paravertebral areas (types 5 and 6), a marginal mar-
gin may be possible only if the lesion is well encapsu-
lated with a fibrous reactive membrane.1,17
3. Surgical strategy for spinal tumors
1) Surgical strategy for primary spinal tumors
Surgical strategy for primary spinal tumors was modi-
fied from the Enneking concept of musculoskeletal
tumors,1 which is shown in Table 1. The main modifica-
tion is that we make a distinction between the potential
of local recurrence from residual tumor tissues and that
from tumor cell contamination after tumor surgery.
This is particularly clear in stage 3 of benign tumors
such as the giant-cell tumor. Total tumor resection
including the tumor capsule, whether in en bloc or
Fig. 1. A Compartment and barrier. SSL,
supraspinous ligament; LF, ligamentum
flavum; PLL, posterior longitudinal liga-
ment; ALL, anterior longitudinal liga-
ment; ISL, interspinous ligament; CL,
costotransverse ligament. B Specimens
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When considering surgery for a patient with spinal
metastasis, our prerequisite is a minimum of 3 points
or less in the Eastern Cooperative Oncology Group
(ECOG) performance status test21 or 30% or more in
the Karnofsky performance scale,22 which are the same
requirements for administrating chemotherapy. Our
scoring system consists of three prognostic factors,
which are regarded as the most influential factors for
life expectancy. These scores are given by each hazard
ratio: (1) pathological/clinical grade of malignancy (low
grade/slow growth), 1 point; intermediate grade/moder-
ate growth, 2 points; high grade/growth, 4 points); (2)
visceral metastases (no metastasis, 0 points; treatable, 2
points; untreatable, 4 points); (3) bone metastases (iso-
lated, 1 point; multiple, 2 points). These three factors
are added together to give a prognostic score of 2–10
points. We found that neurological deficit is not be
an influential factor for life expectancy, so, it is not
counted. The treatment aim for each patient is set ac-
cording to this prognostic score and life expectancy.20
After deciding on the surgical strategy for each pa-
tient along with the treatment aim, the extent of the
spinal metastasis is stratified using “the surgical classifi-
cation of spinal tumors.” Finally, the most technically
appropriate and feasible surgery is employed, such as en

























Fig. 2. Surgical classification of spinal tumors
piecemeal fashion, is mandatory; otherwise, local tumor
invariably recurs from the residual tumor tissues left
behind in this grade of tumors.
Salvage surgery for tumor recurrence in the spine
causes great difficulty because recurrent tumor grows in
the postsurgical scar tissue that adheres to the surround-
ing critical structures (e.g., dura, aorta, vena cava), in
contrast to the long bones. Therefore, first time en bloc
excision to include all tumor margins is most desirable
to prevent local recurrence of malignant spinal tumors
or even aggressive benign tumors, such as the giant-cell
tumor.
2) Surgical strategy for spinal metastases
In the past, the indication for surgical management
of spinal metastases was based on signs of neurologi-
cal deficit, the presence of intractable pain, and spinal
instability, as shown by Harrington.18 Tokuhashi et al.19
originally proposed a prognostic scoring system for
preoperative evaluation of patients with metastatic
spine tumors. We tried to take this approach one step
further and proposed a surgical strategy for spinal
metastases based on a prognostic scoring system to pro-
vide “rough but appropriate and practically easy”
guidelines for the treatment in all patients with various
histological varieties of spinal metastases (Fig. 3).20
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sion), palliative surgery (decompression), or no surgical
treatment. This scoring system should be considered
only as a guideline. The final treatment decision should
be made on an individual case-by-case basis, taking the
family’s will into consideration.
Surgical technique of TES
Each step of the TES technique has been described in
detail in several published articles.2,3
1. Surgical indications
The TES operation was designed to achieve oncological
complete tumor resection en bloc including main and
satellite microlesions in a vertebral compartment to
avoid local recurrence. Primarily, lesions with the follow-
ing pathologies are candidates: primary malignant tumor
(stage I or II); aggressive benign tumor (stage 3); isolated
metastasis with long life expectancy (Table 1, Fig. 3).
From the viewpoint of tumor growth (surgical classi-
fication), TES is recommended for type 3, 4, and 5
Fig. 3. Surgical strategy for spinal
metastases
Table 1. Surgical strategy for primary spinal tumors
Surgical Contamination / Surgical Spinal cord
Staging Residual tumor margin Salvage surgery
Benign tumor:
1. Latent Don’t touch!
2. Active OK / OK intralesional Debulking (piecemeal)
3. Aggressive OK / No intralesional or Thorough excision
marginal (piecemeal / en bloc)
Malignant tumor:
I. Low grade No / No
marginal or wideII. High grade No / No
(radical: impractical)
Total en bloc excision
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1 point = slow growth: Breast ca., Thyroid ca., Prostatic ca., Testicular ca.
2 points = moderate growth: Renal cell ca., Uterus ca., Ovarian ca., Colorectal ca.
4 points = rapid growth: examples: Lung ca., Gastric ca., Esophageal ca., Nasopharyngeal ca.,
Hepatocellular  ca., Pancreas ca., Bladder ca., Melanoma,
Sarcoma (osteosarcoma, Ewing  sarcoma, Leiomyosarcoma,
etc), Other rare ca., Primary unknown metastasis
Rare types of  the following ca. should be given 4 points as a rapidly growing cancer:
    Breast ca.; inflammatory type,     Thyroid ca.; undifferentiated type,     Renal cell ca.; inflammatory type21 3
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lesions; and it is relatively indicated for type 1, 2,
and 6 lesions. Type 1 or 2 lesions can still be a
candidate for radiotherapy, chemotherapy, corpectomy,
or hemivertebrectomy. TES is not recommended for
type 7 lesions; systemic treatment or hospice care may
be the treatment of choice for these lesions (Fig. 2).2,3
2. Surgical approach
The TES technique consists of two steps including en
bloc resection of the posterior element and en bloc
resection of the anterior portion to salvage the spinal
cord. In some cases, a small part (pedicle in most cases)
becomes intralesional deliberately, but it must be un-
avoidable to salvage the spinal cord. The surgical
approach is chosen based on the degree of tumor devel-
opment or the affected spinal level.
1) Single posterior approach
We prefer a single posterior approach rather than a
posteroanterior combined approach for TES above L4,
when the tumor does not involve major vessels (most
type 1, 2, 3, and 4 tumors and some type 5 and 6 tumors).
The main advantage of this approach is that the spi-
nal cord can be observed carefully throughout the
procedure, especially during anterior spinal column
osteotomy, corpectomy, and spinal reconstruction by
posterior instrumentation.
2) Anteroposterior double approach
Anterior dissection followed by posterior TES is indi-
cated for a type 5 or 6 tumor when it involves major
vessels or segmental arteries. Nowadays, thoracoscopic
or a mini-open approach is preferred for anterior
dissection.14
3) Posteroanterior double approach
Posterior laminectomy and stabilization followed by
anterior en bloc corpectomy and placement of vertebral
prosthesis is indicated for spinal tumors at the level of
L5 (L4) because of the technical challenge presented by
the iliac wing and lumbosacral plexus nerves.14
Major risks and possible solutions
The major risks associated with the TES operation are
(1) excessive bleeding; (2) injury of the major vessels
during blunt dissection of the vertebral body; (3) spinal
cord injury; (4) possible contamination by tumor cells
especially intralesional cutting at the pedicle; (5) com-
plete spinal instability resulting from spinal osteotomy.
Possible solutions are described as follows based on our
basic research.
1. How to reduce excessive bleeding
1) Preoperative embolization
Intraoperative bleeding is sometimes excessive in pa-
tients with hypervascular spinal tumors during TES sur-
gery. There is no doubt that preoperative embolization
of the feeding artery at the affected vertebra is manda-
tory, but it does not seem be sufficient to stop bleeding
altogether. In a canine study, we found that when bilat-
eral segmental arteries at three levels were ligated
blood flow of the middle vertebra was reduced to 25%
of that of the control group23 while maintaining 80% of
spinal cord blood flow. Moreover, spinal cord function
was not damaged at all.24
Based on these data, not only a feeding artery alone
but also segmental arteries above and below at three
levels were embolized preoperatively.23,24 Our clinical
results showed that this embolization technique dra-
matically reduced intraoperative bleeding from the
tumor-involved vertebra without compromising spinal
cord function.
2) Hypotensive anesthesia
It has become common practice to manage relatively
hypotensive anesthesia (systolic blood pressure 80–
100mmHg). This does not influence the spinal cord
blood circulation as once was thought.
3) Fibrin glue tamponade into the epidural space
Bleeding from the epidural venous plexus is sometimes
profuse. Meticulous hemostasis by tamponade in the
epidural space using Oxycell cotton® or Aviten® is
mandatory. We developed an additional hemostatic
technique of epidural fibrin glue injection tamponade to
reduce epidural bleeding. It was observed in rats25,26 that
the combination of the two solutions of thrombin and
fibrinogen changes from sol to gel immediately after
epidural injection and has a tamponade effect to reduce
bleeding from the vertebral venous plexus. In clinical
practice, 1.5ml fibrin glue was manually injected into
the epidural space in the craniocaudal direction of the
targeting vertebra, respectively, using a silastic catheter
just after en bloc laminectomy.25 This helps reduce ooz-
ing from the epidural venous plexus.
2. How to avoid damage of major vessel and
segmental vessels
Blunt dissection of the anterior part of the vertebral
body is another risky maneuver during TES using a
single posterior approach. Of course, careful step-by-
step dissection is an important fundamental key, and
each anatomical relation between the vertebra and the
visceral organs, the major vessels, and the segmental
arteries and its spinal branches should be well acknowl-
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edged.27–29 Based on our anatomical studies on cadavers,
it became clear that the dissection is less likely to dam-
age the thoracic aorta or azygos vein between T1 and
T4. However, the segmental artery must be carefully
detached and clipped anteriorly in areas caudal to T5
before manipulation of the affected vertebra. It might
be helpful to remember the use of Prejet® patching
over the pinhole of the aorta in a case of pulling out the
segmental artery. With a lesion of L1 and L2, the dia-
phragm insertions should be dissected from the verte-
bral body before the lumbar arteries are dissected
because the segmental arteries run between the verte-
bral body and diaphragm insertion. Utmost care is
necessary to dissect around the vertebral body in the
lumbar spine because both the aorta and the vena cava
are located close to and in front of the lordotic spine.
After all structures surrounding the vertebral body
are dissected, the following processes are continued
under the protection barricade by a vertebral spatula
(recompartmentalization), which is also useful for limit-
ing the amount of bleeding.
3. How to avoid spinal cord injury
1) Atraumatic handling of the spinal cord
The spinal cord compressed by a tumor is extremely
delicate and fragile. It is common knowledge that one
must avoid mechanical damage to the neural structures,
especially shifting aside, twisting, and hanging the cord
down or up. We also learned from spinal cord mon-
itoring during surgery that stretching the spinal cord
causes irreversible mechanical damage. Too much
nerve root traction also damages the cord owing to root
avulsion.
2) Circumferential (360°) spinal cord decompression
Spinal cord damage had been associated with circum-
ferential spinal cord decompression and “suspension
bridge” shape deformity after TES. However, we have
had many patients with thoracic myelopathy caused by
combined thoracic ossification of the posterior longi-
tudinal ligament and the yellow ligament who had re-
markable neurological recovery after circumferential
spinal cord decompression.30 It has been confirmed
that spinal cord function does not fall into critical condi-
tion even if all the anatomical structures around the
cord are removed. Encouraged by these experiences,
the tumor compressing the cord is totally removed
together with all barrier structures during TES. Spinal
cord monitoring proved that there was remarkable
improvement of spinal cord function after circumspinal
decompression.
3) Ligation of the radicular artery and
Adamkiewicz artery
Possible circulatory compromise after ligation of the
radicular artery is another concern. In the cat model,
we16,31 found that ligation of the Adamkiewicz artery
reduced spinal cord blood flow by approximately 81%
of the control value, and this decrease did not affect
spinal cord evoked potentials.16,31 Woodard and Free-
man32 reported that animals (adult mongrel dogs) that
underwent sectioning of one to four sets of adjacent
nerve roots showed either no neurological deficits or the
deficits were extremely transient; animals with five sets
of adjacent nerve roots sectioned frequently showed
transient neurological deficits.32 It is because the blood
supply of the spinal cord is protected by three arterial
plexus layers: intercanal, dural, and pial arterial plexus.
These structures compensate for the blood supply lost
by ligation of one or two radicular arteries.33 There has
been no neurological degradation due to spinal cord
ischemia in any of the 97 patients in this series who
underwent TES.
4. Risk of tumor cell contamination/tumor
tissue residue
1) T-saw cutting
To cut the vertebral bone sharply while reducing the
risk of spinal cord and nerve root damage, we designed
the T-saw.34 It is composed of multifilament twisted
stainless steel wires and has a smooth surface to cut
bone with minimal damage to the surrounding soft tis-
sue. Its diameter is 0.5 mm, so the cutting loss is negligi-
ble. The T-saw is used during pediculotomy for en bloc
laminectomy and during anterior column osteotomy for
en bloc corpectomy. This T-saw has now been improved
as a “diamond T-saw” for easier cutting.
2) Residual tumor tissue and contaminated tumor cells
Residual tumor tissue and contaminated tumor cells are
different entities from the viewpoint of oncological
regrowth. Residual tumor is certain to regrow if it exists,
whereas the potential of regrowth is low from contami-
nated tumor cells. Residual tumor tissue does not re-
main after TES with an adequate oncological margin,
even if the tumor vertebra is divided into two blocks by
the T-saw (anterior and posterior parts). However, the
risk of tumor cell contamination does exist during this
process.
The potential for tumor growth after “intralesional”
cutting by a T-saw, Gigli saw, and scalpel was compared
using nude mice.35 The number of tumor cells attached
was significantly less with the T-saw than with the Gigli
saw or scalpel. Furthermore, most of the tumor cell
debris created by the T-saw was fragmented and had
low potential for regrowth. Hence, the incidence of
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tumor regrowth after rubbing subcutaneous tissue with
a tumor surface cut with a T-saw was less than that with
a Gigli saw or a scalpel. These findings show that tumor
recurrence is less likely after intralesional tumor cutting
with a T-saw than with a Gigli saw or scalpel. The T-saw
is thus a safer tool for intralesional tumor cutting than
the Gigli saw or scalpel even when intralesional tumor
cutting becomes necessary.35
3) Rinsing with distilled water and anticancer drug
Contamination might be minimal but still a possible
cause of local recurrence after TES surgery. To eradi-
cate contaminated cancer cells, a new local chemo-
therapy was developed: double-rinsing with distilled
water and highly concentrated cisplatinum.36 In an in
vitro experiment, no tumor cells remained alive after
they were exposed to distilled water for 2.5min fol-
lowed by highly concentrated cisplatinum (0.5mg/ml)
for 2.5min. The reason is that osmosis of the tumor cell
membrane is increased by contact with distilled water,
and the permeability of the membrane to cisplatinum
moving into the cytoplasm of the tumor cells is in-
creased, resulting in eradication of contaminated tumor
cells.36
We have experienced local recurrence in only 5 of 97
patients who underwent TES surgery. All of our local
recurrences were at the edge of an unsuccessfully ex-
cised tumor margin, that is, from residual tumor tissue.
Therefore, preoperative planning of the surgical margin
is the most important factor for preventing local recur-
rence caused by residual tumor tissue.1
5. Spinal column instability
1) Spinal column reconstruction
The TES operation includes complete resection of
the affected vertebra(e) and the surrounding musculo-
ligamentous supportive tissues.1 Primary rigid recon-
struction is required for complete spinal instability.37
The authors38 investigated the stiffness of eight pedicle
screws (L1–L5) with an anterior prosthesis alone
[multilevel posterior instrumentation (MPI)] using
finite element analysis. We concluded that the above
reconstruction method was stable enough for primary
fixation, but the reconstructed section might fail be-
cause of fatigue; therefore, biological bony fusion was
required for long-term maintenance of stability.39,40
To achieve grafted bone union, rigid immobiliza-
tion of the graft(s) is required.41 At the same time, ade-
quate stress must be transmitted to the grafted bone
during the reparative period to stimulate the repair as
well.41 The balance between these two factors is most
important.
The authors’ experiment39 shows that a reconstruc-
tion method using additional anterior instrumentation
with posterior pedicle screws [single posterior and ante-
rior instrumentation (SPAI) or multilevel posterior in-
strumentation with anterior instrumentation (MPAI)],
shields stress on the cancellous bone inside the
anterior prosthesis (a titanium mesh cage) to a greater
degree than does the system using posterior pedicle
screw fixation alone (MPI). Thus, a reconstruction
method with no anterior fixation (MPI) might be better
for allowing stress for remodeling of the bone graft
inside the titanium mesh cage. Spinal reconstruction of
MPI with an anterior titanium mesh cage with autog-
enous bone inside is employed in our series in expecta-
tion of long-term maintenance of stability by biological
fusion.39,40
2) Spinal shortening
The posterior instrumentation is adjusted to compress
the inserted vertebral prosthesis slightly to secure it
during a final step of spinal reconstruction by TES. This
process of spinal shortening contains two important ad-
vantages: (1) it increases spinal stability of the anterior
and posterior spinal column and (2) there is an incre-
ment in spinal cord blood flow (SCBF), which improves
spinal cord function. The safety limits and physiological
effects of spinal shortening on the spinal cord were
studied in dogs.42 Acute spinal column shortening can
be characterized into three phases.
Phase 1 (safe range): spinal shortening within one-third
of the vertebral segment, which is characterized by no
deformity of the dural sac or the spinal cord
Phase 2 (warning range): spinal shortening between
one-third and two-thirds of the vertebral segment,
which is characterized by shrinking and buckling
of the dural sac and no deformity of the spinal
cord
Phase 3 (dangerous range): spinal shortening in excess
of two-thirds of the vertebral segment, characterized
by spinal cord deformity and compression by the
buckled dura
Our experiment revealed the interesting and impor-
tant fact that spinal shortening within the safe range
increases SCBF. As mentioned above, the posterior in-
strumentation is adjusted to compress the inserted ver-
tebral prosthesis slightly during a final step of spinal
reconstruction of TES. This maneuver results in slight
spinal shortening, from 5mm to 10mm, which is within
the safe range of the spinal shortening that leads to
increased SCBF. Numerous authors have demonstrated
that reperfusion of SCBF was of paramount importance
for the recovery of spinal cord function after spinal cord
injuries.43–48 In our series, neurologically compromised
patients had a significant recovery after circumspinal
decompression and shortening of the spinal column in
patients undergoing TES.2,3,16 This may be partly due to
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an increase of SCBF achieved by limited (phase 1 and 2)
shortening.
Results
From 1989 to 2003, a total of 284 patients with spinal
tumors (primary tumors in 86 patients; metastasis in 198
patients) had been surgically treated and followed for a
minimum of 2 years at Kanazawa University Hospital.
TES was performed in 33 of the 86 patients with a
primary tumor; 17 patients with a malignant tumor (3
osteosarcomas, 3 Ewing sarcomas, 3 plasmocytomas,
and 2 chondrosarcomas, among others); 16 with
aggressive benign tumors (4 giant-cell tumors, 3
osteoblastomas; and 3 with symptomatic hemangiomas,
among others).
The 5-year survival for the 17 patients with primary
malignant spinal tumors (stages I and II) who under-
went TES was 67%, and that of 16 patients with aggres-
sive benign tumors (stages 2 and 3) was 100%.
During the same periods, TES was performed in 64 of
198 patients with spinal metastasis. Among the 64 pa-
tients with a metastatic tumor, the primary organ was
the kidney in 18 cases, the breast in 15, the thyroid in 9,
the lung in 4, the liver in 4, and others in 14. Debulking
was primarily performed in 70 patients and palliative
surgery (e.g., posterior decompression and stabilization)
in 64 patients with spinal metastasis (Fig. 4). Altogether,
43 of the 64 patients with the prognostic sore of 2, 3, or
4 points who underwent TES had a 2-year survival of
66.6% and a 5-year survival of 46.6% (Fig. 5).
Of the 97 patients, 92 (95%) had no tumor recurrence
until death or at last follow-up. Five patients (5%) had
a local recurrence, and the mean interval from opera-
tion to the recurrence was 22.1 months. All five patients
had the local recurrence from residual tumor tissue. In
two patients the tumor extended farther into the adja-
cent level than we expected; in another two the tumor
recurred from the dural area. Inadequate spinal oste-
otomy was performed followed by curettage of the
remainder of the tumor in one patient.
There was no neurological deterioration posto-
peratively except in one patient who had hyperesthesia
immediately after the operation resulting from distrac-
tion spinal cord irritation due to a large prosthesis. This
patient recovered completely after immediate revision
surgery with spinal shortening. Of the 32 patients with
preoperative paraparesis, 23 improved neurologically
by more than one grade using the Frankel grading
system.
Excessive blood loss is often associated with TES.
Blood loss during TES at the thoracic level of a single
segment was 2800 ml on average during the early phase
of our experience. After using epidural hemostasis by
fibrin glue injection, it decreased to 2300 ml. Preo-
perative embolization of three segments reduced blood
loss still more, to 1300 ml on average (360–1600 ml).
Spinal instrumentation failure after TES was experi-
enced as rod breakage in two cases, screw breakage in
one case, and dislodgment of the vertebral spacer
(AWGC artificial vertebra) in one case. However, since
titanium mesh cage has been applied as the vertebral
spacer (beginning in 1995), we have not experienced
dislodgement, and fusion of the grafted bone inside the
cage has been demonstrated by three-dimensional com-
puted tomography.
Conclusions and future perspectives
We have reviewed our challenging work on spinal
tumor surgery for the last 15 years. Our starting-line
message is that “spinal metastasis is not necessarily an
Fig. 4. Number of patients who underwent each surgery
for spinal metastases (1989–2003). TES, total en bloc
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end-stage condition even if the patient is already para-
plegic”; and our key principle is that “first-time curative
oncologic surgery is the most important of all.” At
the beginning, this goal seemed almost impossible to
achieve for us as spinal surgeons preoccupied with pre-
serving the cord. However, as oncologic surgeons we
understood that en bloc removal of a vertebral tumor,
whether primary or metastatic, was necessary at all
costs. Hence, we had been in a dilemma whether to
salvage spinal cord function at the cost of leaving re-
sidual tumor behind or remove the tumor radically to
save life. Thus, TES has become one of the solutions
and a milestone for us.
While establishing the validity of the TES procedure,
we have faced many difficult problems scientifically and
technically. Each time, however, we considered the
problem “a top priority research theme” and started
experiments and discussions until we found reasonable
solutions1–3,13–16,20,23,24,28,30,34,35,39,40,42 (published in 22
English-language articles).
At the beginning, TES surgery took more than 20 h to
complete, and we struggled with more than 5000-ml
blood losses. After refining our experience in many ways,
it now only takes 6–8h and 1300ml of possible blood loss.
Of course, we continue to improve this surgery — not
only by devising surgical instruments but also looking for
the possibility of applying techniques learned with mini-
mally invasive surgery or endoscopic surgery.
We must remind ourselves that once there is local
recurrence of a spinal tumor salvage revision surgery
becomes extremely difficult or almost impossible.
Therefore, successful first-time TES is the best option
for the patient and should be performed if possible
despite the technical difficulties faced.
At present, TES is regarded as one of the most de-
manding techniques among spine surgeons. It may be
true, however, that as young surgeons learn this surgery
step by step they will eventually master the surgery and
apply it to all spinal conditions, such as deformity,
trauma, infection, degenerative and multioperated back
surgery, and spinal cord surgery. At best, without realiz-
ing, you find yourself “a real spinal surgeon to the back
bone.”
As medical science develops, the treatment for cancer
will continue to progress. In future, effective adjuvant
therapy will play a more important role than ever be-
fore, and survival of metastatic cancer patients will
improve greatly. Eventually, the demand and the
chance to treat spinal metastasis will increase. In such a
circumstance it is ideal that a general disease and local
lesion integrated multidisciplinary treatment strategy
be established.
In the near future, local curative surgery such as TES
will be indicated for an “apparent mass-sized spinal
tumor” that is life-threatening regardless of whether it
produces neurological or biomechanical symptoms. At
the same time, aggressive curettage by minimally inva-
sive surgery or endoscopic surgery may become another
option supported by highly effective adjuvant therapy
to treat residual tumor tissue, thereby avoiding local
recurrence or tertiary metastasis. As a result, those pa-
tients may survive longer as well.
In patients with “smaller lesions” with no symptoms
or signs, radiotherapy or interventional treatment will
assume a main role as a local treatment. Stereotactic
radiosurgery with such instruments as the Novalis® or
Cyber-knife® will become more available. For “seed-
sized disseminated foci or occult microscopic foci,”
more effective systemic treatment such as chemo-
therapy, hormonal therapy, immunotherapy, or gene
therapy must play a major role.
Once we can apply all these treatment tactics more
systematically and effectively, we can say to the patient
that even the presence of multiple spinal metastases no
longer represents a life-threatening disease or an end-
stage condition.
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